Ambu Future Growth

Future criteria checks 4/6

Ambu is forecast to grow earnings and revenue by 29.6% and 11.7% per annum respectively. EPS is expected to grow by 29.6% per annum. Return on equity is forecast to be 10.6% in 3 years.

Key information

29.6%

Earnings growth rate

29.6%

EPS growth rate

Medical Equipment earnings growth	18.8%
Revenue growth rate	11.7%
Future return on equity	10.6%
Analyst coverage	Good
Last updated	10 Apr 2024

Recent future growth updates

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

Recent updates

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

Shareholders Are Raving About How The Ambu (CPH:AMBU B) Share Price Increased 471%

Feb 25

Earnings and Revenue Growth Forecasts

CPSE:AMBU B - Analysts future estimates and past financials data (DKK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2026	6,794	815	540	996	5
9/30/2025	5,982	604	434	861	6
9/30/2024	5,283	398	326	689	6
12/31/2023	4,897	238	501	805	N/A
9/30/2023	4,775	168	192	518	N/A
6/30/2023	4,679	-42	-168	217	N/A
3/31/2023	4,612	-65	-318	119	N/A
12/31/2022	4,545	95	-475	25	N/A
9/30/2022	4,444	93	-463	95	N/A
6/30/2022	4,307	222	-401	185	N/A
3/31/2022	4,152	256	-521	107	N/A
12/31/2021	4,031	176	-419	194	N/A
9/30/2021	4,013	247	-256	328	N/A
6/30/2021	3,858	251	-187	347	N/A
3/31/2021	3,832	281	111	593	N/A
12/31/2020	3,820	290	56	511	N/A
9/30/2020	3,567	241	-135	295	N/A
6/30/2020	3,302	146	-24	366	N/A
3/31/2020	3,128	270	-62	277	N/A
12/31/2019	2,924	296	37	330	N/A
9/30/2019	2,820	317	272	533	N/A
6/30/2019	2,943	515	361	597	N/A
3/31/2019	2,843	411	316	553	N/A
12/31/2018	2,709	372	327	560	N/A
9/30/2018	2,606	337	318	554	N/A
6/30/2018	2,506	318	269	498	N/A
3/31/2018	2,434	288	266	456	N/A
12/31/2017	2,396	281	296	476	N/A
9/30/2017	2,355	301	N/A	462	N/A
6/30/2017	2,299	306	N/A	403	N/A
3/31/2017	2,215	299	N/A	460	N/A
12/31/2016	2,134	267	N/A	420	N/A
9/30/2016	2,084	250	N/A	369	N/A
6/30/2016	2,047	224	N/A	408	N/A
3/31/2016	2,012	169	N/A	269	N/A
12/31/2015	1,963	175	N/A	246	N/A
9/30/2015	1,889	152	N/A	208	N/A
6/30/2015	1,795	171	N/A	141	N/A
3/31/2015	1,710	184	N/A	137	N/A
12/31/2014	1,630	156	N/A	147	N/A
9/30/2014	1,584	151	N/A	183	N/A
6/30/2014	1,543	94	N/A	167	N/A
3/31/2014	1,524	67	N/A	141	N/A
12/31/2013	1,456	40	N/A	148	N/A
9/30/2013	1,383	48	N/A	122	N/A
6/30/2013	1,265	56	N/A	136	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMBU B's forecast earnings growth (29.6% per year) is above the savings rate (0.8%).

Earnings vs Market: AMBU B's earnings (29.6% per year) are forecast to grow faster than the Danish market (13.3% per year).

High Growth Earnings: AMBU B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMBU B's revenue (11.7% per year) is forecast to grow faster than the Danish market (11.1% per year).

High Growth Revenue: AMBU B's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AMBU B's Return on Equity is forecast to be low in 3 years time (10.6%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Ambu Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Recent updates

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Consensus forecasts updated

Second quarter 2022 earnings: Revenues in line with analyst expectations

Price target decreased to kr.137

Less than half of directors are independent

First quarter 2022 earnings: EPS misses analyst expectations

Ambu A/S Revises Revenue Guidance for the Fiscal 2022

Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Upcoming dividend of kr.0.29 per share

Full year 2021 earnings released: EPS kr.0.98 (vs kr.0.98 in FY 2020)

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?